ProHealth me-cfs Vitamin and Natural Supplement Store and Health
Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|

Trending News

10 Celebrities with ME/CFS

The Brain Boosting and Fatigue Fighting B-12

Severe ME/CFS - New Clinical Study

A New International Newsletter on ME/CFS Is Launched

Norwegian ‘Woulds’ (and ‘Wouldn’ts’): The ME/CFS Survey

Clinical Trial Now Recruiting for New ME/CFS Treatment

Biomedical Research Into ME: The 9th Invest in ME International Conference

Simmaron’s next immune study: where’s the weak link?

Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyeli...

Altered Distribution of Lymphocyte Populations in Chronic Fatigue Syndrome Patients

 
Print Page
Email Article

Shortness of Breath in ME/CFS May be Due to CNS Dysregulation

  [ 5 votes ]   [ Post a Comment ]
www.ProHealth.com • March 5, 2013


Editor’s Comment: This study used the CDC “Fukuda” criteria to establish the two CFS cohorts. Although the Fukuda criteria do not require post-exertional malaise, the researchers found a positive correlation between shortness of breath (dyspnea), and “Exertional Exhaustion.” There was also a high occurrence of fibromyalgia (42% and 47%) in the two CFS groups. In the full study the authors suggest that the sensations of dyspnea, including lightheadedness and chest pain, may be due to central nervous system dysregulation, specifically, dysautonomia

Dyspnea in Chronic Fatigue Syndrome (CFS): Comparison of Two Prospective Cross-sectional Studies

~Source: Global Journal of Health Science; Vol. 5, No. 2; 2013

By Murugan Ravindran et al. 

Abstract

Background: Chronic Fatigue Syndrome (CFS) subjects have many systemic complaints including shortness of breath. Dyspnea was compared in two CFS and control cohorts to characterize potential pathophysiological mechanisms.

Methods: Cohort 1 of 257 CFS and 456 control subjects were compared using the Medical Research Council chronic Dyspnea Scale (MRC Score; range 0–5). Cohort 2 of 106 CFS and 90 controls answered a Dyspnea Severity Score (range 0–20) adapted from the MRC Score. Subsets of both cohorts completed CFS Severity Scores, fatigue, quality of life, and systemic complaints questionnaires. Cohort 2 also responded to other Dyspnea, affective and anxiety instruments. A subset had pulmonary function and total lung capacity (TLC) measurements.

Results: MRC Scores were equivalent for females and males in Cohort 1 CFS (1.92 [1.72-2.16]; mean [95% confidence interval]) and controls (0.31 [0.23-0.39]; P < 0.0001 by 2-tailed, unpaired Student's t tests with Bonferroni corrections). Receiver-operator curves identified 2 as the threshold for positive MRC Scores in Cohort 1. This indicated 54% of CFS, but only 3% of controls, had significant Dyspnea. In Cohort 2, the threshold Dyspnea Severity Score of 4 indicated shortness of breath in 67% of CFS and 23% of these controls. Cohort 2 Dyspnea Scores were higher for CFS (7.80 [6.60-9.00]) than controls (2.40 [1.60-3.20]; P < 0.0001). CFS had significantly worse fatigue, other CFS defining criteria and quality of life compared to controls. Although CFS had worse depressive affect and anxiety scores, only the controls showed correlations with Dyspnea Score. Pulmonary function was normal in CFS, but Borg scores and sensations of chest pain and dizziness were significantly greater during testing than controls. TLC was normal except for 2 of 16 CFS who had hyperinflation. A general linear model of Cohort 2 CFS responses linked Dyspnea Scores with rapid heart rate, chest pain and dizziness.

Conclusions: Sensory hypersensitivity without airflow limitation contributed to Dyspnea in CFS. Correlates of Dyspnea in controls were distinct from CFS suggesting different mechanisms.

Source: Global Journal of Health Science; Vol. 5, No. 2; 2013. Murugan Ravindran, Oluwatoyin Adewuyi, Yin Zheng, Uyenphuong Le, Christian Timbol, Samantha Merck, Rania Esteitie, Michelle Cooney, Charles Read, James Baraniuk. Georgetown University, Washington DC, USA

The full article can be accessed HERE.




Join the Discussion Post a Comment 




[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Your Next Order

Featured Products

B-12 Extreme™ B-12 Extreme™
The Most Potent Vitamin B-12 on Earth
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
MitoQ® MitoQ®
Powerful Antioxidant Support to Mitochondria

Natural Remedies

Research Links Green Tea to Weight Loss Research Links Green Tea to Weight Loss
"It's Not Easy Being Green" - But It Is Healthy
Protect Against Sun-Induced Skin Aging From The Inside Out Protect Against Sun-Induced Skin Aging From The Inside Out
The Curcumin Revolution: The Curcumin Revolution: "Golden" Ticket to Better Health
Live Longer: Groundbreaking Research on Omega-3s Live Longer: Groundbreaking Research on Omega-3s

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia 101
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS 101
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE
CONTACT US
PRIVACY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing